| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $6.3M | $5.8M | $12.1M |
| YoY Revenue Growth % | +9.1% | -52.6% | — |
| Gross Profit | -$1.1M | -$5.6M | — |
| Gross Margin % | -16.9% | -50.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$32.5M | -$74.0M | -$52.3M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$32.3M | -$73.5M | -$50.1M |
| EBITDA (Normalized) | -$30.9M | -$72.9M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$18.8M | -$23.7M | -$26.3M |
| Capital Expenditures (CapEx) | $2.0M | $1.4M | — |
| Free Cash Flow (FCF) | -$20.8M | -$25.1M | -$26.3M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $21.2M | $18.2M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $24.7M | $37.3M | — |